,title,source,link,date
54,Determining Who Should Get Quadruplet Vs Triplet Therapy in ...,Cancer Network,news.google.com/articles/CBMib2h0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZGV0ZXJtaW5pbmctd2hvLXNob3VsZC1nZXQtcXVhZHJ1cGxldC12cy10cmlwbGV0LXRoZXJhcHktaW4tbXVsdGlwbGUtbXllbG9tYdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
45,Ivonescimab Challenges Tislelizumab Plus Chemo in Advanced ...,Targeted Oncology,news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2l2b25lc2NpbWFiLWNoYWxsZW5nZXMtdGlzbGVsaXp1bWFiLXBsdXMtY2hlbW8taW4tYWR2YW5jZWQtZWdmci1ucy1uc2NsY9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
11,Up-to-date meta-analysis of long-term evaluations of mesenchymal ...,Newswise,news.google.com/articles/CBMikQFodHRwczovL3d3dy5uZXdzd2lzZS5jb20vYXJ0aWNsZXMvdXAtdG8tZGF0ZS1tZXRhLWFuYWx5c2lzLW9mLWxvbmctdGVybS1ldmFsdWF0aW9ucy1vZi1tZXNlbmNoeW1hbC1zdGVtLWNlbGwtdGhlcmFweS1mb3ItY29tcGxleC1wZXJpYW5hbC1maXN0dWxh0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-26
76,Study: Some Health Care Professionals Found to Spread COVID-19 ...,Pharmacy Times,news.google.com/articles/CBMigAFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L3N0dWR5LXNvbWUtaGVhbHRoLWNhcmUtcHJvZmVzc2lvbmFscy1mb3VuZC10by1zcHJlYWQtY292aWQtMTktbWlzaW5mb3JtYXRpb24tdmlhLXNvY2lhbC1tZWRpYdIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
74,"Interpersonal, Community Factors Influence PrEP Engagement",Pharmacy Times,news.google.com/articles/CBMiXGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvaW50ZXJwZXJzb25hbC1jb21tdW5pdHktZmFjdG9ycy1pbmZsdWVuY2UtcHJlcC1lbmdhZ2VtZW500gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
71,Will Jakaviâ€™s added evidence for PV cure lead to reimbursement in Korea?,KBR,news.google.com/articles/CBMiPWh0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3Lmh0bWw_aWR4bm89MjE5MTbSAUBodHRwczovL3d3dy5rb3JlYWJpb21lZC5jb20vbmV3cy9hcnRpY2xlVmlld0FtcC5odG1sP2lkeG5vPTIxOTE2?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
69,Scientists Identify New Cause for Inherited Neurodegenerative ...,Pharmacy Times,news.google.com/articles/CBMiaWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvc2NpZW50aXN0cy1pZGVudGlmeS1uZXctY2F1c2UtZm9yLWluaGVyaXRlZC1uZXVyb2RlZ2VuZXJhdGl2ZS1kaXNlYXNlc9IBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
67,FDA Approves First Biosimilar of Natalizumab for the Treatment of ...,Pharmacy Times,news.google.com/articles/CBMigQFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L2ZkYS1hcHByb3Zlcy1maXJzdC1iaW9zaW1pbGFyLW9mLW5hdGFsaXp1bWFiLWZvci10aGUtdHJlYXRtZW50LW9mLXJlbGFwc2luZy1tdWx0aXBsZS1zY2xlcm9zaXPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
66,Propulsion of Medullary Thyroid Cancer Clinical Trial Pipeline as ...,Digital Journal,news.google.com/articles/CBMivAFodHRwczovL3d3dy5kaWdpdGFsam91cm5hbC5jb20vcHIvbmV3cy9nZXRuZXdzL3Byb3B1bHNpb24tb2YtbWVkdWxsYXJ5LXRoeXJvaWQtY2FuY2VyLWNsaW5pY2FsLXRyaWFsLXBpcGVsaW5lLWFzLW5vdmVsLWFuZC1leHRlbnNpdmUtMTUtdGhlcmFwaWVzLWxpa2VseS10by1lbnRlci1pbi10aGUtZG9tYWluLWRlbHZlaW5zaWdodNIBAA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
36,FDA Clears Investigational New Drug Application to Treat ...,Pharmacy Times,news.google.com/articles/CBMieWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvZmRhLWNsZWFycy1pbnZlc3RpZ2F0aW9uYWwtbmV3LWRydWctYXBwbGljYXRpb24tdG8tdHJlYXQtYW15b3Ryb3BoaWMtbGF0ZXJhbC1zY2xlcm9zaXPSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-08-25
